222

IL DONG PHARM

No trades
See on Supercharts
Market capitalization
‪421.23 B‬KRW
−2940KRW
‪−78.93 B‬KRW
‪600.76 B‬KRW
‪16.69 M‬
Beta (1Y)
1.08

About IL DONG PHARM

CEO
Woong-Sub Yoon
Headquarters
Seoul
Website
Employees (FY)
‪1.01 K‬
Founded
2016
ISIN
KR7249420001
FIGI
BBG00CF4FTT7
Ildong Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicines, ingredients for medicines, health supplements and special nutritional products. Its products include vitamins, antibiotics, gastric ulcer medicine, peptic ulcerative agents, and diet pills. The company was founded on August 1, 2016 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 249420 is 14900 KRW — it has increased by 0.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange IL DONG PHARM stocks are traded under the ticker 249420.
249420 stock is 2.51% volatile and has beta coefficient of 1.08. Check out the list of the most volatile stocks — is IL DONG PHARM there?
IL DONG PHARM revenue for the last quarter amounts to ‪149.20 B‬ KRW despite the estimated figure of ‪211.00 B‬ KRW. In the next quarter revenue is expected to reach ‪147.90 B‬ KRW.
Yes, you can track IL DONG PHARM financials in yearly and quarterly reports right on TradingView.
249420 stock has risen by 2.69% compared to the previous week, the month change is a 12.61% fall, over the last year IL DONG PHARM has showed a 29.22% decrease.
249420 net income for the last quarter is ‪1.42 B‬ KRW, while the quarter before that showed ‪−46.02 B‬ KRW of net income which accounts for 103.08% change. Track more IL DONG PHARM financial stats to get the full picture.
Today IL DONG PHARM has the market capitalization of ‪414.24 B‬, it has decreased by 2.55% over the last week.
Like other stocks, 249420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IL DONG PHARM stock right from TradingView charts — choose your broker and connect to your account.
249420 reached its all-time high on Apr 6, 2022 with the price of 79500 KRW, and its all-time low was 9280 KRW and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪1.01 K‬ employees. See our rating of the largest employees — is IL DONG PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IL DONG PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IL DONG PHARM stock shows the sell signal. See more of IL DONG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IL DONG PHARM future price: according to them, 249420 price has a max estimate of 23000.00 KRW and a min estimate of 23000.00 KRW. Read a more detailed IL DONG PHARM forecast: see what analysts think of IL DONG PHARM and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IL DONG PHARM EBITDA is ‪−25.10 B‬ KRW, and current EBITDA margin is −4.18%. See more stats in IL DONG PHARM financial statements.